|
FOXN2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.037990E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.828100E-02 |
| Normal-vs-Stage2 |
1.541230E-03 |
| Normal-vs-Stage3 |
1.158910E-03 |
| Normal-vs-Stage4 |
1.225940E-02 |
| Stage1-vs-Stage2 |
2.940100E-02 |
| Stage1-vs-Stage3 |
8.676200E-03 |
| Stage1-vs-Stage4 |
1.543450E-01 |
| Stage2-vs-Stage3 |
8.073800E-01 |
| Stage2-vs-Stage4 |
5.165200E-01 |
| Stage3-vs-Stage4 |
6.098400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.442070E-02 |
| Normal-vs-AfricanAmerican |
1.227240E-01 |
| Normal-vs-Asian |
4.762100E-02 |
| Caucasian-vs-AfricanAmerican |
9.331400E-01 |
| Caucasian-vs-Asian |
9.938600E-01 |
| AfricanAmerican-vs-Asian |
9.359200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.255800E-02 |
| Normal-vs-Female |
8.963900E-03 |
| Male-vs-Female |
6.304800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.542380E-01 |
| Normal-vs-Age(41-60Yrs) |
1.621900E-03 |
| Normal-vs-Age(61-80Yrs) |
1.578910E-03 |
| Normal-vs-Age(81-100Yrs) |
1.565820E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.300500E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.879900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.267400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.719800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.311000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.839800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.252210E-01 |
| Classical-VS-Follicular |
7.138200E-02 |
| Classical-VS-Other |
3.763600E-01 |
| Classical-VS-Normal |
5.346200E-02 |
| Tall-VS-Follicular |
7.302000E-01 |
| Tall-VS-Other |
9.295200E-01 |
| Tall-VS-Normal |
1.439800E-02 |
| Follicular-VS-Other |
7.777000E-01 |
| Follicular-VS-Normal |
5.504700E-03 |
| Other-VS-Normal |
1.473410E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.279500E-03 |
| Normal-vs-N1 |
3.221600E-02 |
| N0-vs-N1 |
4.615400E-01 |
|
|
